Abstract
The SAR of a series of potent sulfonamide hydroxamate TACE inhibitors bearing novel acetylenic P1' groups was explored. In particular, compound 4t bearing a butynyloxy P1' moiety has excellent in vitro potency against isolated TACE enzyme and in cells, good selectivity over MMP-1 and oral activity in an in vivo model of TNF-alpha production.
MeSH terms
-
ADAM Proteins
-
ADAM17 Protein
-
Acetylene / chemistry*
-
Enzyme Inhibitors / chemistry*
-
Enzyme Inhibitors / pharmacology*
-
Hydroxamic Acids / chemistry*
-
Hydroxamic Acids / pharmacology*
-
Metalloendopeptidases / antagonists & inhibitors*
-
Structure-Activity Relationship
-
Sulfonamides / chemical synthesis*
-
Sulfonamides / pharmacology*
-
ortho-Aminobenzoates / chemistry*
-
ortho-Aminobenzoates / pharmacology*
Substances
-
Enzyme Inhibitors
-
Hydroxamic Acids
-
Sulfonamides
-
ortho-Aminobenzoates
-
ADAM Proteins
-
Metalloendopeptidases
-
ADAM17 Protein
-
Acetylene